Moderna CEO says personalized cancer vaccines could expand to multiple cancers, with kidney cancer data potentially released between the end of this year and early next year
Moderna CEO said personalized mRNA cancer vaccines could potentially be used for multiple cancers, with kidney cancer trial data potentially released between the end of this year and early next year. Efficacy in other cancer types and production at scale remain to be validated.